Unacceptable co-formulants


PPPs and adjuvants containing unacceptable co-formulants will no longer be permitted from 24 March 2023

The EU has implemented Commission Regulation (EU) 2021/383adding unacceptable co-formulants to Annex III of the EU PPP Regulation.

This followed lengthy discussions, which the UK participated in when a Member State.

This means that existing NI authorisations for PPPs and adjuvants which contain one or more of these co-formulants must be amended or withdrawn by 24 March 2023. Grace periods as specified in Regulation (EU) 2021/383 will apply.

Independent consideration by HSE with the agreement of the English, Welsh, and Scottish Administrations, has found it appropriate to implement the same changes. As set out in retained legislation applicable in GB, there is to be a GB Statutory Register of unacceptable co-formulants, which will be established on HSE’s website from 24 March 2023. It will be populated with the same list of unacceptable co-formulants as are included in Commission Regulation (EU) 2021/383.

Affected adjuvants and PPPs will also be withdrawn in GB on 24 March 2023, with appropriate grace periods.

HSE will inform stakeholders via our pesticides ebulletin when the register has been published.

HSE has contacted authorisation/permit holders who our records show have PPPs or adjuvants that contain unacceptable co-formulants outlined in the EU update to Annex III. Wherever possible, HSE will seek to help stakeholders mitigate the impacts of the updates.

Read More

HSE, 03-03-23
; https://www.hse.gov.uk/